News

Navigating Retirement: T. Rowe Price's Insights on Assets

Navigating Retirement: T. Rowe Price's Insights on Assets

Understanding Recent Trends in Retirement Plans

Annual Defined Contribution Consultant Study captures viewpoints from prominent consultant firms on key retirement investment themes.

T. Rowe Price, a distinguished asset management firm, has published its comprehensive 2025 Defined Contribution (DC) Consultant Study, gathering insights from 36 leading consultants and advisory firms across the industry. This study reveals pivotal trends affecting retirement planning and asset management, focusing notably on private assets, retirement income, managed accounts, and capital preservation.

The Shift Towards Private Assets in DC Plans

As the landscape of retirement planning continues to evolve, the introduction of alternative assets into DC plans is generating considerable interest among consultants and advisors. The study highlights that a majority of respondents favor incorporating alternative assets primarily through target date solutions. These solutions can either be tailored or off-the-shelf, emphasizing a gradual shift in the way plans are structured to accommodate a broader spectrum of investment strategies.

Anticipated Growth in Private Equity and Credit

In the responses collected, there was a marked increase in expectations for implementing private credit and private equity within DC plans over the next couple of years. This reflects a growing recognition of the potential benefits that these alternative investments can offer, although the path to implementation will likely face hurdles. Specifically, 72% of consultants cited fees as a significant obstacle to the adoption of alternative investments, closely followed by concerns regarding liquidity (44%) and operational complexity (39%).

Retirement Income Solutions Take Center Stage

Retirement income products are beginning to carve out a more substantial niche in the marketplace. The study revealed a notable change in consultants’ perceptions, with fewer expressing ambivalence about their clients' preferences for retirement income compared to previous years. The data points towards systematic withdrawals being deemed the most desirable method for delivering income to retirees. This method scored an impressive rating as consultants also expressed significant interest in connecting target date solutions with income features such as partial annuitization and managed payout capabilities.

Managed Accounts Offer Personalization

Consultants and advisors are increasingly advocating for the integration of managed accounts, which provide a tailored investment approach. The findings state that 37% of firms currently offer managed accounts as an opt-in feature within investment menus. Furthermore, there appears to be growing support for utilizing managed accounts in dynamic Qualified Default Investment Alternatives (QDIAs). In this scenario, participants initially enter target date solutions and later have the option to re-default into managed accounts as they age.

Revisiting Capital Preservation Strategies

The current interest rate environment has prompted consultants to reassess existing capital preservation investments. There’s a renewed focus on the comparative advantages of stable value funds versus money market options, particularly as current money market yields surpass stable value crediting rates. This is a noteworthy shift, as this situation has only occurred twice in the past nearly three decades.

Consultants Advocate for Broader Opportunities

Additional survey outcomes indicate a robust interest among consultants for integrated investment strategies. For instance, 73% of respondents highlighted the importance of diversifying within fixed income as a driving force behind their evaluations of investment opportunities. Further, consultants expressed their preference for active management in credit-oriented fixed income sectors and acknowledged the potential for blended target date solutions encompassing both active and passive strategies.

Anticipating Emerging Financial Solutions

Looking forward, there is anticipation for the growth of in-plan programs addressing student debt and emergency savings. A significant number of respondents (about 85%) believe that these initiatives will gain traction in retirement plans. Interest in the potential applications of artificial intelligence (AI) tools is also prominent, with close to half of the consultants still evaluating practical AI use cases, showcasing a keen interest in leveraging technology to enhance service delivery.

T. Rowe Price: A Leader in Retirement Strategy

Jessica Sclafani, Global Retirement Strategist at T. Rowe Price, expressed that the evolving landscape presents an opportunity for firms to refine their service offerings. Emphasizing the importance of understanding clients' needs, she noted that the insights gathered from the study enable consultants and advisors to assist plan sponsors effectively in navigating both investment complexities and regulatory challenges.

Frequently Asked Questions

What is the focus of the 2025 DC Consultant Study?

The study captures insights from leading consultants about private assets, retirement income, managed accounts, and capital preservation strategies.

How are target date solutions evolving?

Target date solutions are now more commonly integrated with income features, providing a seamless transition from savings to spending phases for retirees.

What challenges do consultants face in implementing alternative assets?

Key obstacles include high fees, liquidity issues, and the operational complexities associated with incorporating alternative investments into retirement plans.

What is the significance of managed accounts in retirement planning?

Managed accounts offer personalization by catering to individual investment preferences and needs, which enhances the overall retirement planning experience for participants.

How is T. Rowe Price positioned in the asset management industry?

T. Rowe Price is a leading global asset management firm with a strong commitment to investment excellence and a focus on client interests, managing substantial assets with a significant portion related to retirement.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 2

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

Insightful Findings on gMG Treatments by UCB at AANEM 2024

Updated Category News Views 127

UCB Highlights Innovations in Generalized Myasthenia Gravis Treatments at AANEM 2024 UCB, a prominent global biopharmaceutical company, is gearing up to present its latest findings in the management of generalized myasthenia gravis (gMG) at the upcoming American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) meeting. The event, which will also feature...

Continue Reading
Lysander Funds Shares New Distributions Estimates for ETFs

Updated Category News Views 131

Lysander Funds Shares New Distributions Estimates Lysander Funds Limited recently made an announcement about the anticipated cash distributions for December 2024 for their exchange-traded funds (ETFs). The focus is on three notable ETFs: Lysander-Slater Preferred Share ActivETF, Lysander-Canso Corporate Treasury ActivETF, and Lysander-Canso Floating Rate ActivETF. Each of...

Continue Reading
Empowering Girls: Pace Center's Initiatives for Growth

Updated Category News Views 350

Introduction to the Capital Campaign Pace Center for Girls Hillsborough is excited to announce its capital campaign aimed at expanding its capacity and enhancing the support provided to girls in the community. Through dedicated efforts such as education, counseling, and training, this campaign signifies a crucial step towards bettering the future for girls in Hillsborough...

Continue Reading
Bank of America Sees Growth in Loans, Deposits Amid Profit Rise

Updated Category News Views 284

Bank of America Reports Increased Earnings and Efficiency Bank of America Corp (NASDAQ: BAC) has announced strong financial results for the second quarter, showcasing impressive growth in loans, deposits, and overall profitability. The bank reported a net income of $7.1 billion, a slight increase from $6.9 billion the previous year, along with an earnings per share (EPS)...

Continue Reading
Investigating Manitex International: A Closer Look at MNTX

Updated Category News Views 72

Examining Fair Treatment for Manitex International Shareholders Ademi LLP has launched an investigation into Manitex International, Inc. (NASDAQ: MNTX) due to concerns about possible breaches of fiduciary duty related to its recent transaction with Tadano. This investigation raises important questions about whether shareholders are being treated fairly in the financial...

Continue Reading